Overview
Worldwide Healthcare Trust invests worldwide in the healthcare sector with the objective of achieving a high level of capital growth. In order to achieve its investment objective, Worldwide Healthcare Trust invests in a diversified portfolio of shares in pharmaceutical and biotechnology companies and related securities in the healthcare sector. It uses gearing and derivative transactions to mitigate risk and also to enhance returns.
Fundamentals
Price
Research History
-
17 Oct 2023 14 min read
QuotedData’s Investment Companies Quarterly Review – Third Quarter 2023
Third quarter of 2023 Investment Companies | Quarterly roundup | October 2023 Kindly sponsored by abrdn ‘Uncomfortable’ Following a fast start to the first half of the year, globally equities took a breather in Q3, as markets assessed the implications of the worst bond sell-off in a generation. Yields on 10-year US treasuries and UK […]
-
13 Oct 2022 14 min read
QuotedData’s Investment Companies Quarterly Review – Third Quarter 2022
Third quarter of 2022 Kindly sponsored by Baillie Gifford and Aberdeen Standard Investments Piling on the misery In the face of rising inflation, exacerbated by the war in Ukraine, central bankers have condemned for their relative inaction. However, in the third quarter of 2022, they stepped up a gear. Last month’s economic and political roundup […]
-
14 Jul 2020 9 min read
QuotedData’s Investment Companies Quarterly Review – Second Quarter 2020
Investment Companies Quarterly Roundup Kindly sponsored by Baillie Gifford and Aberdeen Standard Investments Table of contents In this issue Performance data Positive movers Negative movers Discounts and premiums Getting more expensive Getting cheaper Money in and out Money in Money out Major news stories Upcoming Events New research Guide The legal bit When the going gets […]
-
07 Jul 2020 8 min read
QuotedData’s Economic Roundup – July 2020
Economic & Political Roundup Kindly sponsored by Allianz A collation of recent insights on markets and economies taken from the comments made by chairmen and investment managers of investment companies – have a read and make your own minds up. Please remember that nothing in this note is designed to encourage you to buy or sell […]
-
06 Dec 2019 5 min read
QuotedData’s economic roundup – December 2019
Economic & Political Roundup Kindly sponsored by Polar Capital and Allianz A collation of recent insights on markets and economies taken from the comments made by chairmen and investment managers of investment companies – have a read and make your own minds up. Please remember that nothing in this note is designed to encourage you […]
-
6 min read
QuotedData’s investment companies roundup – December 2019
Investment Companies Roundup Kindly sponsored by Baillie Gifford Table of contents New research In this issue Performance data Discounts and premiums Money in and out Income Events New research Here is a list of research we published over November: An initiation note on Henderson High Income “We have initiated coverage on Henderson High Income (HHI). Since […]
-
07 Oct 2019 5 min read
QuotedData’s investment companies roundup – October 2019
Investment Companies Roundup Kindly sponsored by Baillie Gifford New research Over September, we published notes on India Capital Growth, Jupiter Emerging & Frontier, International Biotechnology Trust, JPMorgan Russian Securities, Civitas Social Housing, Montanaro European Smaller Companies and JLEN Environmental Assets. We also launched a monthly real estate roundup, beginning with reviews of August and September. In […]
-
05 Jul 2019 6 min read
QuotedData’s economic roundup – July 2019
Economic & Political Roundup A collation of recent insights on markets and economies taken from the comments made by chairmen and investment managers of investment companies – have a read and make your own minds up. Please remember that nothing in this note is designed to encourage you to buy or sell any of the […]
-
08 May 2019 3 min read
QuotedData’s investment companies roundup – May 2019
Investment Companies Roundup New research Over April, we published notes on Henderson Diversified Income, Ecofin Global Utilities and Infrastructure, Jupiter Emerging and Frontier Income, Seneca Global Income & Growth and Polar Capital Global Financials Trust. You can read all these notes by clicking on the links above or by visiting www.quoteddata.com. In this issue Performance data – it was […]
-
22 Feb 2019 1 min read
QuotedData’s investment companies roundup – February 2019
QuotedData’s investment companies roundup – February 2019 is our latest roundup of news; price, NAV and discount movements; flows in and out of the sector and report on full year dividends announced over the month of January 2019. Kindly sponsored by Baillie Gifford. December’s sharp sell-off in technology and growth stocks reversed somewhat in January. This was […]
-
18 Jan 2019 1 min read
QuotedData’s investment companies roundup – January 2019
QuotedData’s investment companies roundup – January 2019 is our latest roundup of news; price, NAV and discount movements; flows in and out of the sector and report on full year dividends announced over the month of December 2018. Kindly sponsored by Baillie Gifford. Extract from money raised and returned in December The only new issue […]
-
19 Dec 2018 1 min read
QuotedData’s economic roundup – December 2018
QuotedData’s economic roundup – December 2018 is a collation of recent insights on markets and economies taken from the comments made by chairmen and investment managers of investment companies – have a read and make your own minds up. Please remember that nothing in this note is designed to encourage you to buy or sell any […]
-
12 Oct 2018 1 min read
QuotedData’s investment companies roundup – October 2018
QuotedData’s investment companies roundup – October 2018 is our latest roundup of news; price, NAV and discount movements; flows in and out of the sector and report on full year dividends announced over the month of August 2018. Kindly sponsored by Baillie Gifford. Money raised and returned in September Trian Investors 1 is a new fund that will adopt […]
-
11 Jul 2018 1 min read
QuotedData’s Economic round up – July 2018
QuotedData’s Economic round up – July 2018 is a collation of recent insights on markets and economies taken from the comments made by chairmen and investment managers of investment companies – have a read and make your own minds up. Please remember that nothing in this note is designed to encourage you to buy or […]
-
25 Apr 2018 1 min read
Quarterly investment companies roundup – First quarter 2018
Quarterly investment companies roundup – First quarter 2018 Quarterly investment companies roundup – First quarter 2018 – Global equity markets declined in the first quarter of 2018. Concerns about US interest rate rises were the feature of the first half of the quarter. However, worries about global trade took over in the second part, particularly […]
-
07 Feb 2018 2 min read
QuotedData investment companies roundup – February 2018
QuotedData investment companies roundup – February 2018 – is our latest roundup of news; price, NAV and discount movements; flows in and out of the sector and report on full year dividends announced over the month of January 2018. Kindly sponsored by Baillie Gifford. The oil price was up again over the month and this helped propel […]
-
18 Jan 2018 1 min read
QuotedData – 2017 review of the year
QuotedData – 2017 review of the year – Many commentators, including us, were wary going into 2017. In the event, economic growth and markets surprised on the upside: US markets hit new highs despite three interest rate rises. Perceived low/no growth areas such as Europe and Japan burst into life. Asia’s technology stocks surged. India’s […]
-
10 Jan 2018 2 min read
QuotedData investment companies roundup – January 2018
QuotedData investment companies roundup – January 2018 – is our latest roundup of news; price, NAV and discount movements; flows in and out of the sector and report on full year dividends announced over the month of December 2017. Kindly sponsored by Baillie Gifford. January Investment Companies Roundup Winners and losers in December Infrastructure India’s share price […]
-
11 Dec 2017 2 min read
QuotedData investment companies roundup – December 2017
QuotedData investment companies roundup – December 2017 – is our latest roundup of news; price, NAV and discount movements; flows in and out of the sector and report on full year dividends announced over the month of November 2017. Kindly sponsored by Baillie Gifford. December Investment Companies Roundup Money raised and returned in November There were no […]
-
1 min read
QuotedData’s economic round up – December 2017
QuotedData’s economic round up – December 2017 – is a collation of recent insights on markets and economies taken from the comments made by chairmen and investment managers of investment companies – have a read and make your own minds up. Please remember that nothing in this note is designed to encourage you to buy or […]
-
10 Nov 2017 1 min read
QuotedData investment companies roundup – November 2017
QuotedData investment companies roundup – November 2017 – is our latest roundup of news; price, NAV and discount movements; flows in and out of the sector and report on full year dividends announced over the month of October 2017. Kindly sponsored by Baillie Gifford. November Investment Companies Roundup Globalworth Real Estate’s discount was eliminated after it announced […]
-
12 Oct 2017 1 min read
QuotedData investment companies roundup – October 2017
QuotedData investment companies roundup – October 2017 – is our latest roundup of news; price, NAV and discount movements; flows in and out of the sector and report on full year dividends announced over the month of September 2017. Kindly sponsored by Baillie Gifford. October Investment Companies Roundup Amongst the top performers, Alternative Liquidity Fund sold its […]
-
14 Sep 2017 1 min read
QuotedData investment companies roundup – September 2017
QuotedData investment companies roundup – September 2017 – is our latest roundup of news; price, NAV and discount movements; flows in and out of the sector and report on full year dividends announced over the month of August 2017. Kindly sponsored by Baillie Gifford. September Investment Companies Roundup Winners and losers in August Ashmore Global’s […]
-
12 Jul 2017 2 min read
QuotedData investment companies roundup – July 2017
QuotedData investment companies roundup – July 2017 – is our latest roundup of news; price, NAV and discount movements; flows in and out of the sector and report on full year dividends announced over the month of June 2017. Kindly sponsored by Baillie Gifford. July Investment Companies Roundup Money raised in July Newly launched in June were […]
-
2 min read
QuotedData’s economic round up – July 2017
QuotedData’s economic round up – July 2017 – is a collation of recent insights on markets and economies taken from the comments made by chairmen and investment managers of investment companies – have a read and make your own minds up. Please remember that nothing in this note is designed to encourage you to buy or […]
-
07 Dec 2016 1 min read
QuotedData investment companies roundup – December 2016
Our latest roundup of news; price, NAV and discount movements; flows in and out of the sector and report on full year dividends announced over the month of November 2016. december-investment-companies-roundup
-
1 min read
QuotedData’s round up of views on the global economy – December 2016
QuotedData’s collation of recent insights on markets and economies taken from comments made by chairman and managers of investment companies. december-economic-and-political-roundup
News
-
18 Nov 2024 2 min read
Worldwide Healthcare defends McCutcheon and Borho’s board seats
Worldwide Healthcare (WWH) has issued an announcement following up on the results of its AGM on 10 July 2024, where the resolutions to re-elect Doug McCutcheon and Sven Borho as directors of the company had more than 20% of votes cast against the respective resolutions (all other votes passed comfortably). The board acknowledges that some […]
-
07 Jun 2024 15 min read
Worldwide Healthcare benefits from big pharma, medtech and emerging biotech perfomance
Worldwide Healthcare (WWH) has published its annual results for the year ended 31 March 2024, during which it provided NAV and share price total returns of 12.0% and 8.6% respectively, which compare to a return from its MSCI World Health Care benchmark of 10.9% (all in sterling terms). The difference between the performance of the […]
-
23 Nov 2023 2 min read
QuotedData’s morning briefing 23 November 2023 – ANII, WHH, NRR, LMP
In QuotedData’s morning briefing 23 November 2023: abrdn New India Investment Trust (ANII) announced its interim report for the six months to September 30 2023. Share price total return for the period was 13.7% while the NAV was up 13.2% with the discount narrowing slightly to -18.7% at last close. While impressive on an absolute […]
-
07 Jun 2023 2 min read
Another down year for Worldwide Healthcare
Worldwide Healthcare Trust (WWH) has released its annual report for the year ended 31 March 2023. The company’s net asset value per share total return was -0.1% and the share price total return was -4.1%, underperforming the benchmark MSCI World Health Care Index measured on a net total return, sterling adjusted basis, which returned +2.5% […]
-
23 Nov 2022 5 min read
QuotedData’s morning briefing 23 November 2022
In QuotedData’s morning briefing 23 November 2022: Worldwide Healthcare (WWH) has announced its interim results for the six months ended 30 September 2022. During the period, WWH provided an NAV total return of 3.1%, modestly outperforming its benchmark, the MSCI World Healthcare Index, which returned 2.1% during the period. In absolute terms, net asset value […]
-
22 Jul 2022 3 min read
QD view – Is the tide finally turning for biotech?
In early 2021, it looked like the pandemic had been a breakthrough moment for the biotechnology sector. The sector had been critical in the development of Covid-19 vaccines, using new and innovation gene sequencing, while developments in oncology promised a treatment revolution. Share prices were riding high and specialist investment trusts had enjoyed two years […]
-
27 May 2022 10 min read
Major underperformance for Worldwide Healthcare
Following the announcement earlier today that it has terminated its placing programme (click here to read more), Worldwide Healthcare (WWH) has now announced its annual results for the year ended 31 March 2022. These show that, following the previous year’s strong returns, both on an absolute and on a relative basis, the year under review […]
-
1 min read
QuotedData’s morning briefing 27 May 2022
In QuotedData’s morning briefing 27 May 2022: Worldwide Healthcare (WWH) has announced that it is terminating its placing programme, which was established on 13 July 2021, with immediate effect. WWH expects to publish its annual results later today and, if the placing programme was still in effect, this would have required WWH to publish a […]
-
17 Nov 2021 2 min read
QuotedData’s morning briefing 17 November 2021
In QuotedData’s morning briefing 17 November 2021: Caledonia (CLDN) has agreed terms to divest its investment in BioAgilytix, a leading provider of bioanalytical testing for large molecule research and development, as private equity firm Cinven, becomes the new lead investor. The transaction is subject to US anti-trust approvals and is expected to complete in December […]
-
04 Jun 2021 1 min read
QuotedData’s weekly news show 4 June 2021
QuotedData’s weekly news show 4 June 2021 Thank you to everyone that listened in today, whether you watched the Zoom live, on Facebook or on Youtube. In this week’s show, James Carthew covered the week’s top stories: Scottish Investment Trust update Performance fees this week – Lindsell Train, Worldwide Healthcare, Aurora Brevan Howard funds merger […]
-
3 min read
QD view – on drugs
QD view – on drugs… and other aspects of healthcare. Rate worries hitting growth stocks After delivering impressive returns last year, the tech and biotech sectors have stumbled a bit recently. It seems unfair that trusts such as Polar Capital Technology and Allianz Technology are now trading on discounts. However, some investors are worried about […]
-
03 Jun 2021 7 min read
Worldwide Healthcare expands on benchmark beating returns
Worldwide Healthcare Trust has announced results covering the 12 months ended 31 March 2021. It was a great year for the trust, especially given the backdrop of COVID-19. The NAV total return for the period was 30.0%, well-ahead of the return on the trust’s benchmark (MSCI World Health Care Index) of 16.0%. The shares did […]
-
28 Jan 2021 1 min read
QuotedData’s morning briefing 28 January 2021
In QuotedData’s morning briefing 28 January 2021: VH Global Sustainable Energy Opportunities raised £242.6m from its IPO. Dealings in the ordinary shares will commence at 8.00 a.m. on 2 February 2021. CATCo Reinsurance Opportunities says its unaudited NAVs for the ordinary shares and C shares were $0.2828 and $0.5071 respectively, as at the close of business on […]
-
04 Jun 2020 2 min read
Worldwide Healthcare has positive COVID-19 experience
Worldwide Healthcare results for the year ended 31 March 2020 show an NAV return of 6.5%, ahead of the benchmark’s 5.7%. The premium edged a little higher to 1.8% from 0.3%, giving shareholders a return of 8.0%. The dividend has fallen to 25p from 26.5p – but this trust is not about dividends. The NAV […]
-
10 Jan 2020 2 min read
Biotech Growth tops bio-trust league with 47% NAV rise – updated
Biotech Growth tops bio-trust league with 47% NAV rise – Orbimed-managed Biotech Growth Trust (BIOG) recorded the rise 47% rise in NAV in 2019, representing the best performance of the 14 specialist biotech/pharma closed end investment vehicles monitored by Marten & Co. Biotech Growth’s rise in NAV was more than double that of the benchmark […]
-
06 Jun 2019 1 min read
QuotedData’s other news 6 June 2019
In QuotedData’s other news 6 June 2019: Regional REIT has announced the sale of an office building in Sheffield at a price 25% higher than when it was last valued. Bought in 2016 for £6.3m, Aspect Court, Pond Hill, Sheffield was sold to Sheffield Hallam University for £8.8 million, reflecting a net initial yield of 6.6%. […]
-
23 Jan 2019 2 min read
WWH opens new positions in Takeda and Novartis
WWH opens new positions in Takeda and Novartis Orbimed-managed Worldwide Healthcare Trust (WWH) has disclosed new substantial shareholdings in Takeda – the Japanese pharmaceuticals group that has just completed a takeover of Shire Pharmaceuticals – and Novartis, according to an analysis by Marten & Co. The shareholding in Takeda appears in third place and accounts for […]
-
03 Aug 2018 1 min read
Tekla Healthcare top specialist fund performer in July
Tekla Healthcare top specialist fund performer in July Tekla Healthcare Opportunities, a US closed end fund that invests largely in US large cap pharma and biotech, saw the best investment performance of the 14 specialist biotech specialist investors monitored by Marten & Co, in terms of its sterling-adjusted NAV performance for the month of July. Switzerland’s BB […]
-
20 Jun 2018 2 min read
Alexion files for key drug with priority review voucher
Alexion files for key drug with priority review voucher Trust favourite Alexion Pharmaceuticals (Nasdaq: ALXN) yesterday confirmed it had made a US regulatory submission for approval of ALXN1210, its long-acting C5 complement inhibitor, for the treatment of the ultra-rare condition of paroxysmal nocturnal hemoglobinuria (PNH). Alexion is a cornerstone holding for both the OrbiMed-managed Biotech Growth Trust […]
-
30 Apr 2018 2 min read
OrbiMed-managed trusts benefit from Alexion rise
OrbiMed-managed trusts benefit from Alexion’s rise Shares in trust favourite Alexion Pharmaceuticals (Nasdaq: ALXN) put on 12% last week on the back of a strong financial first quarter with upgraded guidance and positive top-line results from a phase III study of ALXN1210, the company’s longer-acting follow-up to its blockbuster Soliris in the ultra-rate disease of […]
-
17 Apr 2018 2 min read
WWH’s hedging of Merck-BMS data comp backfires
WWH’s hedging of Merck-BMS data comp backfires Worldwide Healthcare Trust’s (WWH) apparent attempt to hedge its bet on the outcome of the three trials of anti-pd(L)-1 checkpoint inhibitors in first-line treatment of non-small cell lung cancer that were reported simultaneously yesterday appears to have backfired, after the stock market determined the data justified an asymmetric response. […]
-
11 Apr 2018 3 min read
Worldwide Health offers a way to play AACR lung data reveal
Worldwide Health offers a way to play AACR lung data reveal London-listed Worldwide Healthcare Trust (WWH) could be best way for trust investors to obtain exposure to what is likely to be the most important clinical data disclosure involving large cap pharmaceutical companies this year. This is set to occur next Monday (16 April) at the American Association […]
-
26 Mar 2018 2 min read
Worldwide Healthcare rejigs portfolio, adds BMS, Vertex stakes
Worldwide Healthcare rejigs portfolio, adds BMS, Vertex stakes OrbiMed-managed Worldwide Healthcare Trust (WWH) has added new large shareholdings in Bristol-Myers Squibb and Vertex to its portfolio, displacing holdings in Intuitive Surgical and Cigna from its top 10, according to the trust’s latest factsheet. The changes follow the addition of a holding in Merck & Co in January, and […]
-
23 Jan 2018 2 min read
HBM Healthcare tops biotech trust league in 2017
HBM Healthcare tops biotech trust league in 2017 Swiss-listed HBM Healthcare Investments (HBMN.S) can claim to have been the best performing biotech-specialist closed-end fund in 2017, according to an analysis by Marten & Co. The CHF1.1bn trust run by Swiss healthcare investment specialist HBM saw its share price rise from CHF99 to CHF134 last year […]
-
18 Dec 2017 1 min read
Investment Trust Insider on Biotech
Investment Trust Insider on Biotech – inspired by the launch of our biotech news service on QuotedData, I wrote something for Citywire that looks at some of the exciting stories that have been published just in the last couple of weeks. James Carthew: biotech boom boosts generalist trusts This week I am returning to the […]
-
07 Dec 2017 1 min read
FDA OK for Alexion’s Soliris in myasthenia gravis
FDA OK for Alexion’s Soliris in myasthenia gravis US approval for Alexion’s complement inhibitor Soliris in anti-acetylcholine receptor antibody-positive generalised myasthenia gravis could double the market for a product that is already selling $3bn/year, if some of the most optimistic sell-siders are to be believed. Soliris, which is famously one of, if not the, most […]
-
13 Oct 2017 1 min read
Manchester & London overseas bet pays off
Manchester & London overseas bet pays off – Manchester & London has published results for the year ended 31 July 2017 that show that the fund delivered a 26.9% return on net assets and a 47.9% return to shareholders over a period when its benchmark (MSCI UK Investable Market Index) returned 14.7%. the share price return […]
-
21 Oct 2016 2 min read
Manchester & London performance improves
Manchester & London reports that, for the year ended 31 July 2016, its NAV increased by 19.8% which they compare to a 4.0% return on the Dow Jones U.K. Total Stock Market Total Return Index. The discount the Shares trade at to their Net Asset Value per Share has widened by 2.2 per cent during […]
-
18 Apr 2016 1 min read
Best and worst performing investment trusts: Unloved commodity, Brazil and Russia funds finally come good
Recovery in commodity prices has boosted investment trusts specialising in the sector Investors also hoping for Brazil revival if leader Dilma Rousseff is ousted Biotech and healthcare hit by fears Democrat party will squeeze drug prices if they win the US http://www.thisismoney.co.uk/money/investing/article-3542148/Unloved-commodity-Brazil-Russia-funds-finally-come-good.html
-
21 Mar 2016 3 min read
All change again for Jupiter Global
Jupiter Global’s board has decided to seek shareholders’ approval for a change in both the company’s investment strategy and name with effect from the general meeting of shareholders which has been convened for next month. These changes are the subject of a circular which has been posted alongside the Half Year report. This is an important […]
-
28 Jan 2016 2 min read
F&C Managed Portfolio beats UK market
F&C Managed Portfolio Trust has published interim results for the six months ended 30 November 2015, announcing a net asset value total return of -5.1% for the Income shares and -2.4% for the Growth shares compared to the FTSE All-Share Index return of -6.4%. The key drivers of the performance of the Growth Portfolio were […]
-
27 Jul 2015 5 min read
F&C Managed Portfolio sees both pools beat the UK market
F&C Managed Portfolio has published results for the year ended 31 May 2015. The NAV total returns for the Income shares were 10.0% and for the Growth shares 12.8% compared to the FTSE All-Share Index of 7.5%. The investment company sector, as measured by the FTSE Equity Investment Instruments Index, returned 13.0%. The annual dividend increased […]
-
20 Jul 2015 1 min read
Investment trusts see largest ever new issue
QuotedData reports that the investment trust sector expanded by about GBP2.4 billion over the second quarter of 2015, taking in close to GBP2.9 billion and handing back just over GBP450 million. The firm comments that many of the funds raising money are not designed to throw off high levels of income, suggesting that investors are […]
-
24 Apr 2015 1 min read
Cayenne Trust says considering proposals for future of the company
The Cayenne Trust’s results for the year ended 31 January 2015 have been published. The company’s net asset value total return and share price total return were both 12.1% for the period. This compares to an 11.6% return on the FTSE All-Share Equity Investments Index. The dividend has been increased from 1.2p to 3.8p. The […]
-
22 Jan 2015 1 min read
F&C Managed Portfolio benefits from strong investment company sector
F&C Managed Portfolio has announced results for the six months that finished on 30 November 2014. The FTSE All-Share Index returned -0.1% over that period but F&C Managed Portfolio Growth shares (FMPG) returned 4.3% and the F&C Managed Portfolio Income shares (FMPI) returned 3.0% over the period. This may be largely down to a good […]
Upcoming Events
In The Press
-
26 Nov 2024 1 min read
Investment trust insider on Trump and healthcare
Investment trust insider on Trump and healthcare – James Carthew: If Trump avoids healthcare pain, now’s a good time to buy Donald Trump’s provocative healthcare appointments have caused uncertainty for drugs developers but the outlook remains positive once the political noise abates. Two weeks ago, I wrote about the potential positive impact of the new […]
-
21 Oct 2024 1 min read
Investment trust insider on annual redemption opportunities
Investment trust insider on annual redemption opportunities – James Carthew: Annual redemptions bring more problems than solutions Yearly redemption opportunities turn trusts into cash cows and don’t even keep discounts narrow, as Bellevue Healthcare has learnt. This week’s focus is on annual redemption opportunities. I made it clear earlier this month, when discussing the demise […]
-
14 May 2024 2 min read
Healthcare funds roar back to life
by Dave Baxter, Investors Chronicle, May 14, 2024: Areas like biotech can be racy at the best of times and especially vulnerable to shifting investor whims. That much has become evident in recent years: the average investment trust in the AIC’s Biotechnology and Healthcare sector made a whopping 21 per cent share price total return […]
-
08 Mar 2024 1 min read
The truly cheap trusts trading on the widest discount relative to their history
By Matteo Anelli, Senior reporter, Trustnet, 07 March 2024: In the investment trusts universe wide discounts are often linked to higher long-term returns – and the data backs up this hypothesis. Since 2018, investing in trusts with a double-digit discount have returned an annualised 13.6% in the following five years, a recent study by the […]
-
03 Jan 2024 1 min read
Are investment trust discounts getting out of hand?
by Jennifer Hill from interactive investor, 28th December 2023: Risk-off sentiment has pushed investment trust discounts to historically wide levels and many boards have been proactively trying to address the issue. This year will be a record for share buybacks with almost £3.5 billion of investment trust share buybacks in the first 11 months, data […]
-
20 Nov 2023 1 min read
Investment trust insider on RTW Biotech
Investment trust insider on RTW Biotech – James Carthew: RTW Biotech will succeed with or without Arix I was singing the praises of capital markets days last week. Last Tuesday, I managed to get along to one held by RTW Biotech Opportunities (RTW). The day was planned some time ago, but the timing was great […]
-
20 Apr 2022 1 min read
Defensives doing well
Jennifer Hill, AIC Compass, 8 April 2022: Jennifer Hill analyses the sectors delivering robust returns. Russia’s invasion of Ukraine feels symbolic, not only of a marked change in the geopolitical landscape but also of a potential regime change in investing. With oil, gas, wheat and many metals soaring in price, already-stubborn inflation is likely to […]
-
05 Apr 2022 1 min read
Investment trust insider on biotech – James Carthew: What’s gone wrong with biotechnology?
About a year ago, I wrote an article on biotech and said that I was minded to stick by my biotech and healthcare investments – Biotech Growth (BIOG), Worldwide Healthcare (WWH) and Syncona (SYNC). In retrospect, this doesn’t look like a great idea. Over the past 12 months, BIOG and SYNC’s shares are down by […]
-
15 Nov 2021 2 min read
The alternative trusts allowing investors to capture new trends
Investment trusts enjoy record year for fundraising as they back a new wave of innovation November 11, 2021, Investors Chronicle, By Mary McDougall Investment trust fundraising amounted to £11.4bn in the first 10 months of the year, a record for the ancient fund structure which is now financing a new wave of innovation. Most striking is the […]
-
24 Mar 2021 1 min read
Investment trust insider on biotech and healthcare
Investment trust insider on biotech and healthcare – James Carthew: Why I will stick with biotech after Covid It is now a year since the market meltdown triggered by the coronavirus. Just beforehand, I wrote an article exploring Orbimed’s thoughts on the US election’s potential impact on the healthcare sector. The manager of the Biotech Growth […]
-
16 Nov 2020 1 min read
How to invest in Big Pharma
A shot in the arm for your portfolio (without side effects): How to invest in Big Pharma with these shares and investment trusts By ANNE ASHWORTH FOR THE DAILY MAIL PUBLISHED: 21:50, 13 November 2020 | UPDATED: 11:53, 14 November 2020 The breakthrough on the Covid-19 vaccine from Pfizer and BioNTech this week has cheered the nation – and the […]
-
25 Feb 2020 2 min read
Investment trust insider on health care
Investment trust insider on health care – James Carthew: healthcare trusts cut through US political noise Just nine months to go until the US election. If only we could lock all the candidates in a room for a year beforehand and harness the hot air. Instead we are condemned to endless opinion polls, voting shenanigans and […]
-
17 Mar 2017 1 min read
Biotech trusts top performance charts in February
Biotech and healthcare trusts came at the top of performance tables in NAV terms in February, as the sector continues to “claw back losses” suffered prior to the US election, according to investment trust analysts QuotedData. read more here
